BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32712321)

  • 1. Concomitant Adenomyosis among Patients with Asherman Syndrome.
    Wang J; Movilla P; Chen T; Wang J; Morales B; Williams A; Reddy H; Tavcar J; Morris S; Loring M; Isaacson K
    J Minim Invasive Gynecol; 2021 Feb; 28(2):358-365.e1. PubMed ID: 32712321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live births after Asherman syndrome treatment.
    Hanstede MMF; van der Meij E; Veersema S; Emanuel MH
    Fertil Steril; 2021 Oct; 116(4):1181-1187. PubMed ID: 34130799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome.
    Deans R; Vancaillie T; Ledger W; Liu J; Abbott JA
    Hum Reprod; 2018 Oct; 33(10):1847-1853. PubMed ID: 30239778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.
    Wang J; Movilla P; Morales B; Wang J; Williams A; Reddy H; Chen T; Tavcar J; Morris S; Loring M; Isaacson K
    J Minim Invasive Gynecol; 2021 Jul; 28(7):1357-1366.e2. PubMed ID: 33065259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of Asherman syndrome and reproductive outcome.
    Hansen BB; Nøhr B
    Dan Med J; 2022 Feb; 69(3):. PubMed ID: 35244019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Asherman's syndrome in an outpatient hysteroscopy setting.
    Bougie O; Lortie K; Shenassa H; Chen I; Singh SS
    J Minim Invasive Gynecol; 2015; 22(3):446-50. PubMed ID: 25497164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyosis: Impact on Fertility and Obstetric Outcomes.
    Buggio L; Dridi D; Barbara G
    Reprod Sci; 2021 Nov; 28(11):3081-3084. PubMed ID: 34231176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study comparing the severity and outcome of intrauterine adhesiolysis for Asherman syndrome after first- or second-trimester termination of pregnancy.
    Zhu R; Gan L; Wang S; Duan H
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():49-53. PubMed ID: 31082744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Asherman syndrome and its hysteroscopic treatment outcomes: experience in a low-resource setting.
    Siferih M; Gebre T; Hunduma F; Abebe A; Gebremichael A; Sewunet H; Shibabaw T
    BMC Womens Health; 2024 Feb; 24(1):99. PubMed ID: 38326846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asherman syndrome--one century later.
    Yu D; Wong YM; Cheong Y; Xia E; Li TC
    Fertil Steril; 2008 Apr; 89(4):759-79. PubMed ID: 18406834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive treatment for infertile women with severe Asherman syndrome.
    Tsui KH; Lin LT; Cheng JT; Teng SW; Wang PH
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):372-5. PubMed ID: 25286793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive Outcomes and Overall Prognosis of Women with Asherman's Syndrome Undergoing IVF.
    Fouks Y; Kidron A; Lavie I; Shapira Z; Cohen Y; Levin I; Azem F; Cohen A
    J Minim Invasive Gynecol; 2022 Nov; 29(11):1253-1259. PubMed ID: 35970266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility?
    Kishi Y; Yabuta M; Taniguchi F
    Fertil Steril; 2014 Sep; 102(3):802-807.e1. PubMed ID: 24954774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
    Alonso L; Nieto L; Carugno J
    J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review.
    Guo EJ; Chung JPW; Poon LCY; Li TC
    Best Pract Res Clin Obstet Gynaecol; 2019 Aug; 59():98-114. PubMed ID: 30713131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the risk factors and incidence of Asherman Syndrome in women with post-abortion uterine curettage.
    Sevinç F; Oskovi-Kaplan ZA; Çelen Ş; Ozturk Atan D; Topçu HO
    J Obstet Gynaecol Res; 2021 Apr; 47(4):1549-1555. PubMed ID: 33462894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis.
    Younes G; Tulandi T
    Fertil Steril; 2017 Sep; 108(3):483-490.e3. PubMed ID: 28865548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive management of severe Asherman syndrome and amenorrhea.
    Myers EM; Hurst BS
    Fertil Steril; 2012 Jan; 97(1):160-4. PubMed ID: 22100167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomyosis and infertility.
    Moawad G; Kheil MH; Ayoubi JM; Klebanoff JS; Rahman S; Sharara FI
    J Assist Reprod Genet; 2022 May; 39(5):1027-1031. PubMed ID: 35347501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of endometriosis and adenomyosis with pregnancy and infertility.
    Vercellini P; Viganò P; Bandini V; Buggio L; Berlanda N; Somigliana E
    Fertil Steril; 2023 May; 119(5):727-740. PubMed ID: 36948440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.